Researcher profile · Semantic Scholar

M. Arquette

h-index: 11
Works: 14
Citations: 1,268

Most-cited papers

Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
R. Herbst, M. Arquette, Dong M. Shin, K. Dicke +4 more
2005Journal of Clinical Oncology364 citations Open access
Semantic Scholar
HER2 Expression in Salivary Gland Carcinomas
B. Glisson, A. Colevas, R. Haddad, J. Krane +8 more
2004Clinical Cancer Research191 citations Open access
Semantic Scholar
Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group.
M. Fisch, P. Loehrer, J. Kristeller, S. Passik +5 more
2003Journal of Clinical Oncology175 citations
Semantic Scholar
A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing
P. Fracasso, H. Burris, M. Arquette, R. Govindan +15 more
2007Clinical Cancer Research157 citations Open access
Semantic Scholar
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
D. Ilson, A. Forastiere, M. Arquette, F. Costa +3 more
2000Cancer Journal138 citations
Semantic Scholar
Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies
P. Fracasso, L. Goldstein, D. de Alwis, J. Rader +9 more
2004Clinical Cancer Research84 citations Open access
Semantic Scholar
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies
P. Fracasso, Kerry J Williams, Ronald Chen, J. Picus +22 more
2010Cancer Chemotherapy and Pharmacology70 citations Open access
Semantic Scholar
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar
P. Fracasso, K. Blum, Margaret K. Ma, Benjamin R. Tan +11 more
2005British Journal of Cancer30 citations Open access
Semantic Scholar
A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report.
D. Kelsen, Robert J. Ginsberg, M. Bains, J. Cooper +3 more
1997Seminars in Oncology22 citations
Semantic Scholar
Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.
M. Arquette, T. Wasserman, R. Govindan, D. Garfield +3 more
2002Seminars in Radiation Oncology15 citations
Semantic Scholar
Phase I study of rubitecan and gemcitabine in patients with advanced malignancies.
P. Fracasso, Janet S. Rader, R. Govindan, Thomas J. Herzog +8 more
2002Annals of Oncology11 citations Open access
Semantic Scholar
Ifosfamide in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck: a phase II Hoosier Oncology Group trial.
A. Sandler, S. Saxman, M. Bandealy, D. Heilman +3 more
1998American Journal of Clinical Oncology11 citations
Semantic Scholar
A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.
R. Govindan, W. Lim, M. Arquette, S. A. Goodner +3 more
2006Oncology Report3 citations Open access
Semantic Scholar
Fluoxetine V ersus P lacebo i n A dvanced C ancer O utpatients: A Double-Blinded T rial o f t he H oosier O ncology G roup
M. Fisch, P. Loehrer, J. Kristeller, S. Passik +5 more
20030 citations
Semantic Scholar

R. Govindan

×3

J. Picus×3

M. Kies×2

M. Fisch×2

P. Loehrer×2

J. Kristeller×2

S. Passik×2

Sin-Ho Jung×2